Thomas Lund
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Self-administration of Subcutaneous Elranatamab in the Patients' Homes. (NCT06015542) | Thomas Lund | 2025-01-29 |
| Home Treatment With Carfilzomib in Patients With Multiple Myeloma (NCT05620238) | Thomas Lund | 2022-12-15 |
| Daratumumab Provided at Home Experience An Open, Single-center, Mixed-method Project. (NCT05306587) | Thomas Lund | 2022-04-01 |
| Bone Healing During Ninlaro Exposure (NCT04028115) | Thomas Lund | 2019-10-24 |
Track Thomas Lund automatically
Every clearance here is in the API, with alerts when new ones post.